We realize that these are unprecedented times for all of us and the Cancer Center wants you to know that we are here for you.
Browse Radiation Oncology News
View COVID-19 Information for Cancer Center Patients, including FAQs.
Congratulations to Abbey Clarkin, a radiation therapist at Mass General Cancer Center, for being named WEEI Sports Radio Network's Everyday Amazing Healthcare Professional of this weekend's and next week's Boston Red Sox games!
Episode #37 of the Charged podcast from Massachusetts General Hospital. Listen now.
Math models add up to improved cancer immunotherapy. Math models add up to improved cancer immunotherapy. Key Takeaways • Mathematical models that represent the complex interactions within the tumor microenvironment can predict how tumors may
Ted Hong, MD, radiation oncologist and avid hockey player discusses explains how the Mass General Cancer Center’s multidisciplinary approach to developing care plans for patients is so beneficial to the patient. He also talks about his love for the game of hockey and the beauty of teamwork.
Nikki Schindler was just 10 years old when she was diagnosed with a Medulloblastoma, a rare form of brain cancer. Since then, Nikki has used her voice to advocate and raise funds for childhood cancer research.
Novel protocol significantly improves outcomes in locally advanced pancreatic cancer - Massachusetts General Hospital, Boston, MA
A Massachusetts General Hospital clinical trial of a treatment protocol for pancreatic cancer has produced unprecedented results – allowing complete removal of the tumor in 61 percent of participants and significantly improving survival rates.
Tumor-selective angiotensin blockers may improve response to cancer immunotherapy - Massachusetts General Hospital, Boston, MA
A research team led by investigators at Massachusetts General Hospital and the Massachusetts Institute of Technology has found that combining a specialized version of an antihypertension drug with immune checkpoint blockers could increase the effectiveness of cancer immunotherapies.
Study reveals how brain tumors escape the effects of antiangiogenic drugs - Massachusetts General Hospital, Boston, MA
A study led by investigators from Massachusetts General Hospital and the University of Cyprus reveals details of a way the dangerous brain tumors called glioblastomas resist the effects of antiangiogenic drugs designed to cut off their blood supply, identifying what may be a new treatment target.